Contributors: Ajisegiri Sewedo, Salaam Ridwan, Adekoya Adepeju, Mansour Balqees, Otuekong Emmanuel, Abodunrin Elizabeth.

## **Functional Enrichment Analysis and Top Three Pathways**

Pathway enrichment analysis (PEA), a computational methodology, was utilized to discover biological pathways with overrepresented genes in glioblastoma cells. Gene lists were created, enrichment analysis was performed using ShinyGO, and significant pathways were highlighted using a lollipop plot. Here, the pathways are described below:<!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span> SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span><![endif]--><!--[if gte vml 1]><v:rect
 id="Rectangle_x0020_3" o:spid="_x0000_s1026" style='width:24pt;height:24pt;
 visibility:visible;mso-wrap-style:square;mso-left-percent:-10001;
 mso-top-percent:-10001;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:char;mso-position-vertical:absolute;
 mso-position-vertical-relative:line;mso-left-percent:-10001;mso-top-percent:-10001;
 v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" filled="f" stroked="f">
 <o:lock v:ext="edit" aspectratio="t"/>
 <w:wrap type="none"/>
 <w:anchorlock/>
</v:rect><![endif]--><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><v:shape
 id="_x0000_i1025" type="#_x0000_t75" style='width:24pt;height:24pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span><![endif]-->

**The cytokine-cytokine receptor interaction pathway** is critical for immune responses, inflammation, and cell signaling, playing roles in processes such as hematopoiesis and tissue repair. Cytokines, including interleukins (ILs), interferons (IFNs), tumor necrosis factors (TNFs), and chemokines, are released by cells in response to infection, injury, or inflammation<sup>1</sup>. These cytokines bind to specific receptors on the surface of target cells, triggering intracellular signaling. Cytokine receptors usually consist of one to three chains, with an alpha chain for ligand binding and beta or gamma chains involved in signal transduction.

When cytokines bind, the receptors activate, often through the involvement of Janus kinases (JAKs). JAKs phosphorylate the receptor, leading to the recruitment and activation of STAT proteins. Once phosphorylated, STAT proteins dimerize and move to the nucleus to regulate gene expression<sup>2</sup>. This process leads to biological responses like immune modulation, cell proliferation, differentiation, and survival. Genes activated in this pathway include those for cytokines, chemokines, and immune response regulators <sup>2, 3</sup>.

Feedback mechanisms like suppressor of cytokine signaling (SOCS) proteins control this pathway to prevent excessive immune responses. SOCS proteins inhibit JAK activity, maintaining the balance of immune signaling and avoiding chronic inflammation or autoimmunity <sup>2</sup>.

**Viral protein interaction with cytokine and cytokine receptor pathway** can alter host immunity, allowing viruses to evade detection and enhance their survival. Some viruses produce cytokine homologs, like viral interleukin-10 (vIL-10), which mimics the anti-inflammatory properties of human IL-10<sup>4</sup>. This allows viruses to suppress immune responses and persist within the host. Others block cytokine receptors or produce receptor homologs that bind cytokines without transmitting signals, disrupting the host’s immune response. For example, blocking the JAK-STAT pathway can hinder the host’s ability to mount an effective antiviral defense<sup>5</sup>.

**The chemokine signaling pathway**, activated during inflammation, attracts immune cells to infection sites. Chemokines bind to G-protein-coupled receptors (GPCRs) on immune cells, activating signaling cascades involving kinases (PI3K, MAPK), adaptor proteins (AKT, NF-κB), and second messengers like cAMP. This leads to gene expression changes, cell migration, and immune cell recruitment. Like cytokine signaling, this pathway is tightly regulated to maintain balance, with receptor internalization and G-protein deactivation ensuring controlled immune responses <sup>6,7</sup>.

 

**References**

1. Guillermo Arango Duque and Albert Descoteaux (2014). Macrophage cytokines: involvement in immunity and infectious diseases. _Front. Immunol_, vol 5.


2. Morris, R., Kershaw, N. J., & Babon, J. J. (2018). The molecular details of cytokine signaling via the JAK/STAT pathway. _Protein science: a publication of the Protein Society_, _27_(12), 1984–2009.


3. Schreiber, G., & Walter, M. R. (2010). Cytokine-receptor interactions as drug targets. _Current opinion in chemical biology_, _14_(4), 511–519.


4. Druszczyńska, M., Godkowicz, M., Kulesza, J., Wawrocki, S., & Fol, M. (2022). Cytokine Receptors-Regulators of Antimycobacterial Immune Response. _International journal of molecular sciences_, _23_(3), 1112.


5. Christiaansen, A., Varga, S. M., & Spencer, J. V. (2015). Viral manipulation of the host immune response. _Current opinion in immunology_, _36_, 54–60.


6. Wang J, Knaut H. (2014). Chemokine signaling in development and disease. Development. 141(22):4199-205.


7. Hughes CE, Nibbs RJB. (2018). A guide to chemokines and their receptors. FEBS J. 285 (16):2944-2971.

** **
